Login to Your Account



Clinic Roundup


Friday, September 13, 2013
• Coronado Biosciences Inc., of Burlington, Mass., said it initiated a National Institutes of Health-sponsored Phase II study evaluating TSO (Trichuris suis ova, CNDO-201) for the treatment of ulcerative colitis (UC).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription